In a significant step toward understanding the earliest signs of Alzheimer’s disease, researchers have uncovered how the brain’s immune system may contribute to one of its first symptoms: the loss of smell. This discovery, published in Nature Communications, offers a potential new pathway for early diagnosis and intervention, particularly important as treatments like amyloid-beta antibodies are most effective in the disease’s initial stages. The study, led by scientists from DZNE and Ludwig-Maximilians-Universität München (LMU), reveals how immune-driven nerve fiber damage could be the underlying cause of olfactory dysfunction in Alzheimer’s patients.

Loss of smell, or olfactory dysfunction, has long been observed as an early warning sign of Alzheimer’s, often appearing before memory issues or other cognitive symptoms. However, the biological mechanism behind this sensory change remained unclear. The new research suggests that the brain’s immune cells, known as microglia, may be mistakenly dismantling vital neural connections between two key brain regions: the olfactory bulb and the locus coeruleus.

The olfactory bulb, located in the forebrain, is responsible for processing scent signals received from the nose. The locus coeruleus, situated in the brainstem, modulates this processing through long noradrenergic nerve fibers. According to Dr. Lars Paeger of DZNE and LMU, the locus coeruleus plays a broad role in regulating physiological functions such as blood flow in the brain, sleep-wake cycles, and sensory processing — including the sense of smell.

“Our study suggests that in early Alzheimer’s disease, changes occur in the nerve fibers linking the locus coeruleus to the olfactory bulb,” Paeger explained. “These alterations signal to the microglia that affected fibers are defective or superfluous. Consequently, the microglia break them down.”

What triggers this immune response? The researchers found that affected nerve fibers exhibited a shift in their membrane composition. Specifically, phosphatidylserine — a fatty acid typically found on the inner side of a neuron’s membrane — was observed on the outer surface. This change acts as an “eat-me” signal to microglia, prompting them to remove the neurons as if they were damaged or unnecessary. This process, known as synaptic pruning, is usually beneficial in brain development and maintenance, but in this context, it may be contributing to the early symptoms of Alzheimer’s.

“In our situation, we assume that the shift in membrane composition is triggered by hyperactivity of the affected neurons due to Alzheimer’s disease,” Paeger noted. “That is, these neurons exhibit abnormal firing.”

I found this detail striking — that a natural cellular process, designed to maintain brain health, could inadvertently contribute to disease when misdirected. It underscores the complexity of Alzheimer’s and the delicate balance of immune activity in the brain.

The study’s conclusions are supported by a robust set of data, including experiments on genetically modified mice that mimic Alzheimer’s pathology, analysis of human brain tissue from deceased patients, and PET scans of individuals with Alzheimer’s or mild cognitive impairment. This comprehensive approach strengthens the case for an immunological mechanism behind early olfactory dysfunction.

Professor Jochen Herms, a co-author of the study and a research leader at DZNE and LMU, emphasized the significance of these findings. “Smell issues in Alzheimer’s disease and damage to the associated nerves have been discussed for some time. However, the causes were unclear until now,” he said. “Now, our findings point to an immunological mechanism as cause for such dysfunctions — and, in particular, that such events already arise in the early stages of Alzheimer’s disease.”

This revelation holds promise for early diagnosis. Current Alzheimer’s treatments, such as amyloid-beta antibodies, show the most benefit when administered before significant cognitive decline occurs. Identifying patients at risk earlier could allow for timely intervention, potentially slowing disease progression.

“Our findings could pave the way for the early identification of patients at risk of developing Alzheimer’s,” Herms added. “This would allow earlier intervention with amyloid-beta antibodies, increasing the probability of a positive response.”

For those concerned about Alzheimer’s, especially individuals noticing changes in their sense of smell, this research offers a hopeful development. While more work is needed to translate these findings into clinical practice, the discovery of this “eat-me” signal and the role of microglia in early nerve fiber loss adds a crucial piece to the Alzheimer’s puzzle. It also highlights the importance of interdisciplinary research, combining neuroscience, immunology, and advanced imaging techniques to better understand this complex disease.

As the scientific community continues to explore the early indicators of Alzheimer’s, studies like this one provide a clearer map of the disease’s progression and open new doors for preventative care. With early detection, there is potential not only to treat but to transform the trajectory of Alzheimer’s before memory loss begins.

Read more at scitechdaily.com